ACCORSI BUTTINI, EUGENIA
 Distribuzione geografica
Continente #
NA - Nord America 232
EU - Europa 213
AS - Asia 126
SA - Sud America 2
OC - Oceania 1
Totale 574
Nazione #
US - Stati Uniti d'America 230
IT - Italia 101
SG - Singapore 58
FI - Finlandia 35
CN - Cina 29
DE - Germania 28
HK - Hong Kong 19
TR - Turchia 13
CZ - Repubblica Ceca 8
GB - Regno Unito 8
IE - Irlanda 8
PL - Polonia 6
SE - Svezia 6
IN - India 5
UA - Ucraina 5
FR - Francia 4
BR - Brasile 2
CA - Canada 2
GR - Grecia 2
RU - Federazione Russa 2
AU - Australia 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
Totale 574
Città #
Singapore 51
Chandler 32
Helsinki 32
Brescia 29
Hong Kong 19
New York 19
Boardman 16
Fairfield 15
Ashburn 14
Seattle 14
Istanbul 12
Shanghai 12
Milan 10
Munich 10
Barlassina 8
Brno 8
Dublin 8
Woodbridge 8
Wilmington 7
Cambridge 6
Jacksonville 6
Romola 6
Houston 5
Los Angeles 5
Pune 5
Wroclaw 5
Pescara 4
Princeton 4
Rome 4
Florence 3
Lappeenranta 3
Athens 2
Bosio 2
Casanova Lonati 2
Chicago 2
Chiswick 2
Des Moines 2
Mazzano 2
Montesilvano Marina 2
São Paulo 2
Turin 2
Beijing 1
Bergamo 1
Brooklyn 1
Cachan 1
Changchun 1
Chengdu 1
Guangzhou 1
Hounslow 1
Jinan 1
Kocaeli 1
La Spezia 1
Lequio Tanaro 1
London 1
Malmo 1
Margherita di Savoia 1
Melbourne 1
Ningbo 1
North Bergen 1
North York 1
Ramallah 1
Redwood City 1
Riyadh 1
Roverbella 1
Santa Clara 1
Shijiazhuang 1
St Petersburg 1
Strasbourg 1
Tianjin 1
Warsaw 1
Totale 429
Nome #
Feasibility of tumor‑derived exosome enrichment in the onco‑hematology leukemic model of chronic myeloid leukemia 124
High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review 58
P1450: AUTOLOGOUS STEM CELL TRANSPLANTATION INDUCES HIGHER LEVEL OF EXHAUSTED T-CELLS IN DLBCL PATIENTS BEFORE LEUKAPHERESIS FOR CAR-T CELL THERAPY 56
PF404 TUMOR-DERIVED EXOSOMES MAY BE USED AS NEW INFORMATIVE TOOL FOR THE DETECTION OF BONE MARROW RESIDUAL CML LEUKEMIC CELLS ACTIVITY 49
PB2209: HIGH RISK MYELODYSPLASTIC SYNDROME DEVELOPING IN A PATIENT AFTER CHIMERIC ANTIGEN RECEPTOR (CAR) T- CELL THERAPY FOR RELAPSED DIFFUSE LARGE B CELL LYMPHOMA 44
Results of an Innovative Program for Surveillance, Prophylaxis, and Treatment of Infectious Complications Following Allogeneic Stem Cell Transplantation in Hematological Malignancies (BATMO Protocol) 35
Feasibility of Leukemia-Derived Exosome Enrichment and Co-isolated dsDNA Sequencing in Acute Myeloid Leukemia Patients: A Proof of Concept for New Leukemia Biomarkers Detection 34
Malnutrition Prevention after Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT): A Prospective Explorative Interventional Study with an Oral Polymeric Formulation Enriched with Transforming Growth Factor Beta 2 (TGF-β2) 29
Timely Leukapheresis May Interfere with the “Fitness” of Lymphocytes Collected for CAR-T Treatment in High Risk DLBCL Patients 27
Successful CAR-T cell therapy in a refractory MCL patient with bacterial, fungal and COVID-19 infection: a case report 25
Bone marrow CD34+ molecular chimerism as an early predictor of relapse after allogeneic stem cell transplantation in patients with acute myeloid leukemia 24
Autologous Stem Cell Transplantation before Lymphocyte Apheresis for CAR-T Cells Therapy Negatively Impacts on T-Cells Fitness and NK Cell Levels in DLBCL Patients 24
Pre-Emptive Donor Lymphocyte Infusion As Optimal Treatment for Relapsed Acute Myeloid Leukemias and Myelodysplastic Syndromes Following Allogeneic Stem Cell Transplantation: Insights from a French-Italian Study on 134 Patients 22
CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation 22
Donor Lymphocyte Infusion in the Treatment of Post-Transplant Relapse of Acute Myeloid Leukemias and Myelodysplastic Syndromes Significantly Improves Overall Survival: A French–Italian Experience of 134 Patients 13
Totale 586
Categoria #
all - tutte 5.626
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.626


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202048 0 0 0 0 10 9 6 6 7 4 1 5
2020/202132 1 2 2 1 1 7 0 4 2 7 1 4
2021/202223 0 0 0 6 0 1 0 1 0 4 7 4
2022/2023132 7 2 3 18 12 23 0 13 17 7 16 14
2023/2024207 6 7 18 14 24 40 4 14 22 4 4 50
2024/2025143 7 27 13 60 36 0 0 0 0 0 0 0
Totale 586